Connection

WILLIAM PEACOCK to Predictive Value of Tests

This is a "connection" page, showing publications WILLIAM PEACOCK has written about Predictive Value of Tests.
Connection Strength

0.962
  1. Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores. Am J Emerg Med. 2017 May; 35(5):704-709.
    View in: PubMed
    Score: 0.084
  2. ST2 in emergency department patients with noncardiac dyspnea. Acad Emerg Med. 2013 Nov; 20(11):1207-10.
    View in: PubMed
    Score: 0.067
  3. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013 Jul 09; 62(2):150-160.
    View in: PubMed
    Score: 0.065
  4. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum. Am Heart J. 2011 Nov; 162(5):893-9.
    View in: PubMed
    Score: 0.058
  5. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
    View in: PubMed
    Score: 0.058
  6. Acoustic cardiography augments prolonged QRS duration for detecting left ventricular dysfunction. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):316-28.
    View in: PubMed
    Score: 0.044
  7. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
    View in: PubMed
    Score: 0.043
  8. Navigating the Observation Zone: Do Risk Scores Help Stratify Patients With Indeterminate High-Sensitivity Cardiac Troponins? Circulation. 2024 01 02; 149(1):70-72.
    View in: PubMed
    Score: 0.034
  9. Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. Am J Emerg Med. 2021 08; 46:170-175.
    View in: PubMed
    Score: 0.027
  10. Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 2000 Mar; 35(3):213-20.
    View in: PubMed
    Score: 0.026
  11. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study. Ann Emerg Med. 2020 07; 76(1):1-13.
    View in: PubMed
    Score: 0.026
  12. The role of atrial fibrillation in the short-term outcomes of patients with acute heart failure. Clin Res Cardiol. 2019 Jun; 108(6):622-633.
    View in: PubMed
    Score: 0.024
  13. Copeptin to rule out myocardial infarction in Blacks versus Caucasians. Eur Heart J Acute Cardiovasc Care. 2019 Aug; 8(5):395-403.
    View in: PubMed
    Score: 0.023
  14. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The?ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.023
  15. Prohormones in the Early Diagnosis of Cardiac Syncope. J Am Heart Assoc. 2017 12 14; 6(12).
    View in: PubMed
    Score: 0.022
  16. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2018 01 23; 137(4):354-363.
    View in: PubMed
    Score: 0.022
  17. Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
    View in: PubMed
    Score: 0.022
  18. External validation of the multivariable 'In-hospital Mortality for PulmonAry embolism using Claims daTa' prediction rule in the Premier Hospital Database. Eur Heart J Qual Care Clin Outcomes. 2017 04 01; 3(2):157-159.
    View in: PubMed
    Score: 0.021
  19. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017 Feb; 35(2):274-280.
    View in: PubMed
    Score: 0.021
  20. External validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction rule. Int J Clin Pract. 2016 Jan; 70(1):82-8.
    View in: PubMed
    Score: 0.019
  21. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial. JACC Cardiovasc Imaging. 2015 Nov; 8(11):1272-1281.
    View in: PubMed
    Score: 0.019
  22. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial. Emerg Med J. 2016 Jan; 33(1):23-9.
    View in: PubMed
    Score: 0.019
  23. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63.
    View in: PubMed
    Score: 0.019
  24. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 2013 Jun; 1(3):192-9.
    View in: PubMed
    Score: 0.016
  25. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013 Oct 03; 168(3):2186-94.
    View in: PubMed
    Score: 0.016
  26. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J. 2013 Aug; 30(8):633-7.
    View in: PubMed
    Score: 0.016
  27. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail. 2012 Jan; 14(1):22-31.
    View in: PubMed
    Score: 0.015
  28. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011 Mar 26; 377(9771):1077-84.
    View in: PubMed
    Score: 0.014
  29. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study. Am J Cardiol. 2011 Mar 15; 107(6):821-6.
    View in: PubMed
    Score: 0.014
  30. Japanese-Western consensus meeting on biomarkers. Int Heart J. 2011; 52(5):253-65.
    View in: PubMed
    Score: 0.014
  31. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010 May 11; 55(19):2062-76.
    View in: PubMed
    Score: 0.013
  32. Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers. Rev Cardiovasc Med. 2010; 11 Suppl 2:S3-12.
    View in: PubMed
    Score: 0.013
  33. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging. 2009 Jul; 2(7):897-907.
    View in: PubMed
    Score: 0.012
  34. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. Circ Cardiovasc Imaging. 2009 Jul; 2(4):339-48.
    View in: PubMed
    Score: 0.012
  35. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol. 2008 Jan 15; 101(2):231-7.
    View in: PubMed
    Score: 0.011
  36. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007 May 15; 49(19):1943-50.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.